Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry

Q2 Medicine Respiratory Medicine: X Pub Date : 2021-11-01 DOI:10.1016/j.yrmex.2020.100025
Spyridon Fortis , Emily S. Wan , Ken Kunisaki , Patrick Tel Eyck , Zuhair K. Ballas , Russell P. Bowler , James D. Crapo , John E. Hokanson , Chris Wendt , Edwin K. Silverman , Alejandro P. Comellas
{"title":"Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry","authors":"Spyridon Fortis ,&nbsp;Emily S. Wan ,&nbsp;Ken Kunisaki ,&nbsp;Patrick Tel Eyck ,&nbsp;Zuhair K. Ballas ,&nbsp;Russell P. Bowler ,&nbsp;James D. Crapo ,&nbsp;John E. Hokanson ,&nbsp;Chris Wendt ,&nbsp;Edwin K. Silverman ,&nbsp;Alejandro P. Comellas","doi":"10.1016/j.yrmex.2020.100025","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The burden of frequent respiratory exacerbations in COPD patients with mild-to-moderate spirometric impairment and smokers with preserved lung function is unknown.</p></div><div><h3>Methods</h3><p>We categorized COPD participants in COPDGene with post-bronchodilator FEV1%predicted≥50% by the annual exacerbation frequency into three groups: i)frequent exacerbators (top 5%; n = 109), ii)exacerbators (&gt;0 but less than frequent exacerbators; n = 1,009), and iii)No exacerbation (n = 981). Exacerbations were defined as respiratory episodes requiring antibiotics and/or systemic steroids. We performed a Cox proportional hazards regression analysis to examine the association with mortality. We repeated the same process in current/former smokers with preserved spirometry (FEV1≥80%predicted and FEV1/FVC≥0.7).</p></div><div><h3>Results</h3><p>Among 2,099 COPD participants, frequent exacerbators had ≥1.8 exacerbations/year and were responsible for 34.3% of the total exacerbations. There were 102 (10.4%) deaths in the group with no exacerbations, 119 (11.8%) in the exacerbator group, and 24 (22%) in the frequent exacerbators. Adjusted mortality in frequent exacerbators was higher relative to individuals with no exacerbations (hazard ratio (HR) = 1.98; 95%CI = 1.25–3.13). An increase in frequency of exacerbations by one exacerbation/year was associated with increased mortality (HR = 1.40,95%CI = 1.21–1.62). Among 3,143 participants with preserved spirometry, frequent exacerbators had ≥0.8 exacerbations/year and were responsible for more than half of the exacerbations. There were 93 (4.2%) deaths in the group with no exacerbations, 28 (3.8%) in the exacerbator group, and 14 (7.6%) in the frequent exacerbators. The adjusted mortality was increased in frequent exacerbators with preserved spirometry relative to those with no exacerbations (HR = 2.25; 95%CI = 1.26–4.01).</p></div><div><h3>Conclusions</h3><p>In COPD participants with mild-to-moderate spirometric impairment and smokers with preserved spirometry, the frequent exacerbator phenotype is responsible for a large proportion of total exacerbations and associated with high mortality.</p></div>","PeriodicalId":37129,"journal":{"name":"Respiratory Medicine: X","volume":"3 ","pages":"Article 100025"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.yrmex.2020.100025","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory Medicine: X","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590143520300129","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Background

The burden of frequent respiratory exacerbations in COPD patients with mild-to-moderate spirometric impairment and smokers with preserved lung function is unknown.

Methods

We categorized COPD participants in COPDGene with post-bronchodilator FEV1%predicted≥50% by the annual exacerbation frequency into three groups: i)frequent exacerbators (top 5%; n = 109), ii)exacerbators (>0 but less than frequent exacerbators; n = 1,009), and iii)No exacerbation (n = 981). Exacerbations were defined as respiratory episodes requiring antibiotics and/or systemic steroids. We performed a Cox proportional hazards regression analysis to examine the association with mortality. We repeated the same process in current/former smokers with preserved spirometry (FEV1≥80%predicted and FEV1/FVC≥0.7).

Results

Among 2,099 COPD participants, frequent exacerbators had ≥1.8 exacerbations/year and were responsible for 34.3% of the total exacerbations. There were 102 (10.4%) deaths in the group with no exacerbations, 119 (11.8%) in the exacerbator group, and 24 (22%) in the frequent exacerbators. Adjusted mortality in frequent exacerbators was higher relative to individuals with no exacerbations (hazard ratio (HR) = 1.98; 95%CI = 1.25–3.13). An increase in frequency of exacerbations by one exacerbation/year was associated with increased mortality (HR = 1.40,95%CI = 1.21–1.62). Among 3,143 participants with preserved spirometry, frequent exacerbators had ≥0.8 exacerbations/year and were responsible for more than half of the exacerbations. There were 93 (4.2%) deaths in the group with no exacerbations, 28 (3.8%) in the exacerbator group, and 14 (7.6%) in the frequent exacerbators. The adjusted mortality was increased in frequent exacerbators with preserved spirometry relative to those with no exacerbations (HR = 2.25; 95%CI = 1.26–4.01).

Conclusions

In COPD participants with mild-to-moderate spirometric impairment and smokers with preserved spirometry, the frequent exacerbator phenotype is responsible for a large proportion of total exacerbations and associated with high mortality.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
轻度至中度肺功能损害的COPD患者和肺量正常的吸烟者频繁加重与死亡率增加相关
背景:轻至中度肺功能障碍的COPD患者和肺功能保留的吸烟者频繁呼吸恶化的负担尚不清楚。方法:我们将COPD基因中支气管扩张剂后fev1预测≥50%的COPD参与者按年加重频率分为三组:i)频繁加重者(前5%;N = 109), ii)加重因子(>0但少于频繁加重因子;n = 1009), iii)无恶化(n = 981)。病情恶化被定义为需要抗生素和/或全身性类固醇的呼吸发作。我们进行了Cox比例风险回归分析,以检验其与死亡率的关系。我们在保留肺活量测定(预测FEV1≥80%,FEV1/FVC≥0.7)的当前/曾经吸烟者中重复了相同的过程。结果在2099名COPD参与者中,频繁加重者每年加重≥1.8次,占总加重次数的34.3%。无加重组102例(10.4%)死亡,加重组119例(11.8%)死亡,频繁加重组24例(22%)死亡。频繁加重者的调整死亡率高于无加重者(危险比(HR) = 1.98;95%ci = 1.25-3.13)。加重频率每增加1次/年与死亡率增加相关(HR = 1.40,95%CI = 1.21-1.62)。在3143名保留肺活量测定的参与者中,频繁加重者≥0.8次/年,造成了一半以上的加重。无加重组有93例(4.2%)死亡,加重组有28例(3.8%)死亡,频繁加重组有14例(7.6%)死亡。保留肺活量的频繁加重者的校正死亡率高于无加重者(HR = 2.25;95%ci = 1.26-4.01)。结论:在轻度至中度肺功能障碍的COPD患者和保留肺功能的吸烟者中,频繁加重因子表型是导致总加重的主要原因,并与高死亡率相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Respiratory Medicine: X
Respiratory Medicine: X Medicine-Pulmonary and Respiratory Medicine
自引率
0.00%
发文量
0
审稿时长
18 weeks
期刊最新文献
Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry Computerized respiratory sounds in paediatrics: A systematic review A single home visit improves adherence and reduces healthcare utilization in patients with frequent exacerbations of Severe Asthma and COPD Converging pathways in pulmonary fibrosis and Covid-19 - The fibrotic link to disease severity Urinary fibrinopeptide-A as a predictive biomarker of exacerbation in asthma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1